|
1
|
Heinegard D, Bayliss M and Lorenzo P:
Biochemistry and metabolism of normal and osteoarthritic cartilage.
Osteoarthritis. Brandt KD, Doherty M and Lohmander LS: Oxford
University Press; New York, NY: pp. 74–84. 1998
|
|
2
|
Pritzker K: Pathology of osteoarthritis.
Osteoarthritis. Brandt KD, Doherty M and Lohmander LS: Oxford
University Press; New York, NY: pp. 50–61. 1998
|
|
3
|
Kim HA and Blanco FJ: Cell death and
apoptosis in osteoarthritic cartilage. Curr Drug Targets.
8:333–345. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang X, Chen L, Xu X, Li C, Huang C and
Deng CX: TGF-β/Smad3 signals repress chondrocyte hypertrophic
differentiation and are required for maintaining articular
cartilage. J Cell Biol. 153:35–46. 2001.
|
|
5
|
Iannone F, De Bari C, Scioscia C, Patella
V and Lapadula G: Increased Bcl-2/p53 ratio in human osteoarthritic
cartilage: a possible role in regulation of chondrocyte metabolism.
Ann Rheum Dis. 64:217–221. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou HW, Lou SQ and Zhang K: Recovery of
function in osteoarthritic chondrocytes induced by
p16INK4a-siRNA in vitro. Rheumatology. 43:555–568. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tetlow LC and Woolley DE: Histamine
stimulates the proliferation of human articular chondrocytes in
vitro and is expressed by chondrocytes in osteoarthritic cartilage.
Ann Rheum Dis. 62:991–994. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hulleman E, Bijvelt JJ, Verkleij AJ,
Verrips CT and Boonstra J: Nuclear translocation of
mitogen-activated protein kinase p42MAPK during the ongoing cell
cycle. J Cell Physioll. 180:325–333. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ekholm SV, Zickert P, Reed SI and
Zetterberg A: Accumulation of cyclin E is not a prerequisite for
passage through the restriction point. Mol Cell Biol. 21:3256–3265.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Massagué J: G1 cell-cycle control and
cancer. Nature. 432:298–306. 2004.
|
|
11
|
Tashiro E, Tsuchiya A and Imoto M:
Functions of cyclin D2 as an oncogene and regulation of cyclin D1
expression. Cancer Sci. 98:629–635. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Musgrove EA, Caldon CE, Barraclough J,
Stone A and Sutherland RL: Cyclin D as a therapeutic target in
cancer. Nat Rev Cancer. 11:558–572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Poi M and Tsai MD: Regulatory
mechanisms of tumor suppressor P16(INK4A) and their relevance to
cancer. Biochemistry. 50:5566–5582. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Witkiewicz AK, Knudsen KE, Dicker AP and
Knudsen ES: The meaning of p16(ink4a) expression in tumors:
functional significance, clinical associations and future
developments. Cell Cycle. 10:2497–2503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bensky D, Clavey S, Stöger E and Gamble A:
Chinese Herbal Medicine: Materia Medica. 3rd edition. Eastland
Press; Seattle, WA: 2004
|
|
16
|
Ho LJ and Lai JH: Chinese herbs as
immunomodulators and potential disease-modifying antirheumatic
drugs in autoimmune disorders. Curr Drug Metab. 5:181–192. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Peng HR: Grand Dictionary of Chinese
Medicinal Formula (Zhong Yi Fang Ji Da Ci Dian). 1. 1st edition.
People’s Health Press; Beijing: pp. 11131993
|
|
18
|
Scheid V, Bensky D, Ellis A and Barolet R:
Chinese Herbal Medicine: Formulas and Strategies. 2nd edition.
Eastland Press; Seattle, WA: 2009
|
|
19
|
Sun SM: Bei Ji Qian Jin Yao Fang. 8. 1st
edition. People’s Medical Publishing House; Beijing: pp. 166–167.
1982
|
|
20
|
Zheng CS, Xu XJ, Ye HZ, Wu GW, Li XH,
Huang SP and Liu XX: Computational approaches for exploring the
potential synergy and polypharmacology of Duhuo Jisheng Decoction
in the therapy of osteoarthritis. Mol Med Rep. 7:1812–1818.
2013.PubMed/NCBI
|
|
21
|
The Ministry of Science and Technology of
the People’s Republic of China. Guidance Suggestions for the Care
and Use of Laboratory Animals. 2006.
|
|
22
|
Murat N, Karadam B, Ozkal S, Karatosun V
and Gidener S: Quantification of papain-induced rat osteoarthritis
in relation to time with the Mankin score. Acta Orthop Traumatol
Turc. 41:233–237. 2007.PubMed/NCBI
|
|
23
|
Garstang SV and Stitik TP: Osteoarthritis:
epidemiology, risk factors, and pathophysiology. Am J Phys Med
Rehabil. 85(Suppl 11): S2–S11. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chan E, Tan M, Xin J, Sudarsanam S and
Johnson DE: Interactions between traditional Chinese medicines and
Western therapeutics. Curr Opin Drug Discov Devel. 13:50–65.
2010.PubMed/NCBI
|
|
25
|
Khanna D, Sethi G, Ahn KS, Pandey MK,
Kunnumakkara AB, Sung B, Aggarwal A and Aggarwal BB: Natural
products as a gold mine for arthritis treatment. Curr Opin
Pharmacol. 7:344–351. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huh JE, Lee WI, Seo BK, Baek YH, Lee JD,
Choi DY and Park DS: Gastroprotective and safety effects of
WIN-34B, a novel treatment for osteoarthritis, compared to NSAIDs.
J Ethnopharmacol. 137:1011–1017. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shortkroff S and Yates KE: Alteration of
matrix glycosaminoglycans diminishes articular chondrocytes’
response to a canonical Wnt signal. Osteoarthritis Cartilage.
15:147–154. 2007.PubMed/NCBI
|
|
28
|
Chan BY, Fuller ES, Russell AK, et al:
Increased chondrocyte sclerostin may protect against cartilage
degradation in osteoarthritis. Osteoarthritis Cartilage.
19:874–885. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang JG, Xia C, Zheng XP, et al:
17β-Estradiol promotes cell proliferation in rat osteoarthritis
model chondrocytes via PI3K/Akt pathway. Cell Mol Biol Lett.
16:564–575. 2011.
|
|
30
|
Kashiwagi A, Schipani E, Fein MJ, Greer PA
and Shimada M: Targeted deletion of Capn4 in cells of the
chondrocyte lineage impairs chondrocyte proliferation and
differentiation. Mol Cell Biol. 30:2799–2810. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang M, Xie R, Hou W, et al: PTHrP
prevents chondrocyte premature hypertrophy by inducing
cyclin-D1-dependent Runx2 and Runx3 phosphorylation, ubiquitylation
and proteasomal degradation. J Cell Sci. 122:1382–1389. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee HP, Chen YL, Shen HC, Lo WH and Hu YC:
Baculovirus transduction of rat articular chondrocytes: roles of
cell cycle. J Gene Med. 9:33–43. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Löwenheim H, Reichl J, Winter H, et al: In
vitro expansion of human nasoseptal chondrocytes reveals distinct
expression profiles of G1 cell cycle inhibitors for replicative,
quiescent, and senescent culture stages. Tissue Eng. 11:64–75.
2005.
|
|
34
|
Aszodi A, Hunziker EB, Brakebusch C and
Fässler R: Beta1 integrins regulate chondrocyte rotation, G1
progression, and cytokinesis. Genes Dev. 17:2465–2479. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Singh S, Johnson J and Chellappan S: Small
molecule regulators of Rb-E2F pathway as modulators of
transcription. Biochim Biophys Acta. 1799:788–794. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bhaduri S and Pryciak PM: Cyclin-specific
docking motifs promote phosphorylation of yeast signaling proteins
by G1/S Cdk complexes. Curr Biol. 21:1615–1623. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu D, Liu J, Lin B, et al: Lewis y
regulate cell cycle related factors in ovarian carcinoma cell RMG-I
in vitro via ERK and Akt signaling pathways. Int J Mol Sci.
13:828–839. 2012. View Article : Google Scholar : PubMed/NCBI
|
